NEW YORK (GenomeWeb) – Sygnis said today that it has signed a non-exclusive distribution agreement for its TruePrime product family with Ozyme France.

Under the terms of the agreement, Ozyme will be able to promote, market, and sell existing and future TruePrime products to molecular biologists in France.

TruePrime products combine Sygnis' recently discovered DNA primase TthPrimPol and the Phi29 polymerase, and enable the amplification of total genomic DNA from exceedingly small amounts of sample, down to the single-cell level, without requiring synthetic primers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.